Nammi D, Srimath-Tirumala-Peddinti RCPK, Neelapu NRR (2016) Identification of drug targets in Helicobacter pylori by in silico analysis: possible therapeutic implications for gastric cancer
It highlights both its contemporary relevance to question enthusiastic expectations about AI applications in planning practice, as well as the need to integrate it with new insights that may reduce a number of anxieties
found that the expression of iNOS and the increased level of the downstream product NO in chondrocytes work together to maintain the role of inflammatory cytokines, which will further cause chondrocyte damage (Martel-Pelletier et al., 1999)
4d), suggesting that the intracellular abundance of substrates for gluconeogenesis determines the expressions of their regulatory enzymes
Key Points The growth hormone (GH)insulin-like growth factor (IGF) axis consists of central neuro-anatomical, regulatory and genetic systems, and the peripheral intracellular GH signalling pathway The introduction of recombinant human GH (rhGH) in 1985 ended the phase of pituitary-derived human growth hormone (hGH) and its associated limitations and risks, opening the possibility of widespread clinical use GH deficiency (GHD) is a syndrome with many different causes and is associated with alterations in growth, body composition and metabolism In some non-GHD short stature disorders, rhGH has been proved effective and is used as a surrogate for the currently unknown, pathophysiologically appropriate treatment Risks of hGH therapy might relate to its direct effects on growth, its anti-insulin action and its cell-proliferating activity
